{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:32:43Z","timestamp":1790314363788,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Province Medical Research Funding","award":["No.2022314"],"award-info":[{"award-number":["No.2022314"]}]},{"name":"Guangdong Province Medical Research Funding","award":["No.2022326"],"award-info":[{"award-number":["No.2022326"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.8210050633"],"award-info":[{"award-number":["No.8210050633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No.2020A1515110735"],"award-info":[{"award-number":["No.2020A1515110735"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2019A1515011984"],"award-info":[{"award-number":["No. 2019A1515011984"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>TORCH (Toxoplasma gondii [TOX], Cytomegalovirus [CMV], Rubella virus [RV], and Herpes simplex virus [HSV]) represents pathogens known to traverse the maternal-fetal barrier and cause severe neonatal anomalies. We aimed to assess the prevalence of preconception TOX, CMV, and RV infections among women with fertility desire in southern China, and identify related risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were obtained from a population-based cross-sectional study conducted as part of the National Free Preconception Health Examination Project. Women planning to conceive within the next 6 months in Guangdong Province were enrolled between 2014 and 2019. Information on sociodemographic, gynecological, and obstetric characteristics was collected. Sera were analyzed for TOX IgG, CMV IgG, and RV IgG antibodies using an enzyme-linked immunosorbent assay. Descriptive, univariate, and multivariate logistic regression analyses were performed to assess the association between TORCH infections and related factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 2,409,137 participants, the prevalence of IgG antibodies for TOX, CMV, and RV was 3.20% (95% <jats:italic>CI<\/jats:italic>: 3.18\u20133.22%), 77.67% (95% <jats:italic>CI<\/jats:italic>: 77.62\u201377.71%) and 76.03% (95% <jats:italic>CI<\/jats:italic>: 75.98\u201376.07%), respectively. Of all participants, 141,047 women (5.85%, 95% <jats:italic>CI<\/jats:italic>:5.83\u20135.88%) reported a history of immunization for RV. Women living in the Pearl River Delta, a more developed region, have significantly lower vaccination rates than those living in other regions. The seropositivity of TOX IgG was highest among women aged 35 years and above, with primary or lower education levels, and rural registration. Factors such as being older, having a higher educational level, and being of other ethnicities were associated with a higher prevalence of naturally acquired CMV and RV infections. Women living in the Pearl River Delta showed a higher risk of TOX, CMV, and RV infections, with a<jats:italic>OR<\/jats:italic>s of 2.21, 4.45, and 1.76, respectively. A history of pregnancy, gynecological diseases, and sexually transmitted infections were potentially associated with TORCH infections, but this association varied across pathogens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings of this study update the baseline of preconception TORCH infections among women with fertility desire in southern China, helping to estimate the risk of congenital infection and guide the development and implementation of effective prevention measures for preconception TORCH infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02560-4","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T18:02:12Z","timestamp":1691690532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of preconception TORCH infections and its influential factors: evidence from over 2\u00a0million women with fertility desire in southern China"],"prefix":"10.1186","volume":"23","author":[{"given":"Lu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"2560_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clp.2014.11.001","volume":"42","author":"N Neu","year":"2015","unstructured":"Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42:77\u2013103.","journal-title":"Clin Perinatol"},{"key":"2560_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-021-00610-y","volume":"20","author":"CJ Megli","year":"2022","unstructured":"Megli CJ, Coyne CB. Infections at the maternal\u2013fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20:67\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"2560_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chom.2017.04.007","volume":"21","author":"N Arora","year":"2017","unstructured":"Arora N, Sadovsky Y, Dermody TS, Coyne CB. Microbial Vertical transmission during human pregnancy. Cell Host Microbe. 2017;21:561\u20137.","journal-title":"Cell Host Microbe"},{"key":"2560_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","volume":"91","author":"PR Torgerson","year":"2013","unstructured":"Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501\u20138.","journal-title":"Bull World Health Organ"},{"key":"2560_CR5","unstructured":"Rubella vaccines: WHO position paper - July. 2020. https:\/\/www.who.int\/publications-detail-redirect\/WHO-WER9527. Accessed 30 Sep 2022."},{"key":"2560_CR6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(21)02691-X","volume":"399","author":"AK Winter","year":"2022","unstructured":"Winter AK, Moss WJ, Rubella. The Lancet. 2022;399:1336\u201346.","journal-title":"The Lancet"},{"key":"2560_CR7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","volume":"320","author":"E Miller","year":"1982","unstructured":"Miller E, Cradock-Watson JohnE, Pollock Thomas M. Consequences of confirmed maternal rubella at successive stages of pregnancy. The Lancet. 1982;320:781\u20134.","journal-title":"The Lancet"},{"key":"2560_CR8","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/cid\/cit059","volume":"56","author":"M Leruez-Ville","year":"2013","unstructured":"Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013;56:1428\u201335.","journal-title":"Clin Infect Dis"},{"key":"2560_CR9","doi-asserted-by":"crossref","unstructured":"Kilby MD, Ville Y, Acharya G. Screening for cytomegalovirus infection in pregnancy. BMJ. 2019;:l6507.","DOI":"10.1136\/bmj.l6507"},{"key":"2560_CR10","doi-asserted-by":"crossref","first-page":"e107645","DOI":"10.1371\/journal.pone.0107645","volume":"9","author":"S Zhang","year":"2014","unstructured":"Zhang S, Hu L, Chen J, Xu B, Zhou Y-H, Hu Y. Cytomegalovirus seroprevalence in pregnant women and association with adverse Pregnancy\/Neonatal outcomes in Jiangsu Province, China. PLoS ONE. 2014;9:e107645.","journal-title":"PLoS ONE"},{"key":"2560_CR11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385\u201394.","journal-title":"Int J Parasitol"},{"key":"2560_CR12","doi-asserted-by":"crossref","first-page":"e6007","DOI":"10.1097\/MD.0000000000006007","volume":"96","author":"S Wang","year":"2017","unstructured":"Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H, et al. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine. 2017;96:e6007.","journal-title":"Medicine"},{"key":"2560_CR13","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.","journal-title":"Rev Med Virol"},{"key":"2560_CR14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/jog.13638","volume":"44","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroepidemiological map of Toxoplasma gondii infection and associated risk factors in preconception period in China: a nationwide cross-sectional study. J Obstet Gynaecol Res. 2018;44:1134\u20139.","journal-title":"J Obstet Gynaecol Res"},{"key":"2560_CR15","doi-asserted-by":"crossref","first-page":"631411","DOI":"10.3389\/fpubh.2021.631411","volume":"9","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Seroprevalence of Cytomegalovirus and Associated factors among Preconception Women: a cross-sectional Nationwide Study in China. Front Public Health. 2021;9:631411.","journal-title":"Front Public Health"},{"key":"2560_CR16","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2017.04.044","volume":"35","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, et al. Rubella virus immunization status in preconception period among chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35:3076\u201381.","journal-title":"Vaccine"},{"key":"2560_CR17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.4269\/ajtmh.20-0137","volume":"105","author":"X Qin","year":"2021","unstructured":"Qin X, Zhang S, Liu H, Cheng G, Liu Y, Hu M, et al. Seroepidemiology of TORCH infections among 1.7 million women of Childbearing Age in Rural China: a Population-Based cross-sectional study. Am J Trop Med Hyg. 2021;105:1202\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2560_CR18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12889-015-1642-4","volume":"15","author":"S Chimhuya","year":"2015","unstructured":"Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015;15:294.","journal-title":"BMC Public Health"},{"key":"2560_CR19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3855\/jidc.11373","volume":"13","author":"D Mhandire","year":"2019","unstructured":"Mhandire D, Rowland-Jones S, Mhandire K, Kaba M, Dandara C. Epidemiology of Cytomegalovirus among pregnant women in Africa. J Infect Dev Ctries. 2019;13:865\u201376.","journal-title":"J Infect Dev Ctries"},{"key":"2560_CR20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.micpath.2018.07.041","volume":"123","author":"R-L Jiang","year":"2018","unstructured":"Jiang R-L, Ma L-H, Ma Z-R, Hou G, Zhao Q, Wu X. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China. Microb Pathog. 2018;123:398\u2013401.","journal-title":"Microb Pathog"},{"key":"2560_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/154.4.357","volume":"154","author":"JL Jones","year":"2001","unstructured":"Jones JL. Toxoplasma gondii infection in the United States: Seroprevalence and Risk factors. Am J Epidemiol. 2001;154:357\u201365.","journal-title":"Am J Epidemiol"},{"key":"2560_CR22","doi-asserted-by":"crossref","unstructured":"Avelino MM, Campos J\u00fanior D, de Parada JB, de Castro AM. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz J Infect Dis. 2004;8.","DOI":"10.1590\/S1413-86702004000200007"},{"key":"2560_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijid.2015.03.005","volume":"34","author":"W Gelaye","year":"2015","unstructured":"Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41\u20135.","journal-title":"Int J Infect Dis"},{"key":"2560_CR24","unstructured":"Guangdong Provincial Statistical Information Network. Guangdong Statistical Yearbook 2015-20. http:\/\/stats.gd.gov.cn\/gdtjnj\/index.html. Accessed 25 Dec 2022."},{"key":"2560_CR25","unstructured":"Zhang S, Wang Q, Shen H. Design of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:162\u20135."},{"key":"2560_CR26","unstructured":"Wang Q, Zhang M, Zhang S, Hu M, Liu N, Kang X. Establishment of quality assurance system of the National Free Preconception Health Examination Project in China. Zhonghua Yi Xue Za Zhi. 2015;:166\u20138."},{"key":"2560_CR27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4269\/ajtmh.17-0677","volume":"98","author":"JL Jones","year":"2018","unstructured":"Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii infection in the United States, 2011\u20132014. Am J Trop Med Hyg. 2018;98:551\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"2560_CR28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/microorganisms9030574","volume":"9","author":"FE Fuchs","year":"2021","unstructured":"Fuchs FE, Pauly M, Black AP, H\u00fcbschen JM. Seroprevalence of ToRCH Pathogens in Southeast Asia. Microorganisms. 2021;9:574.","journal-title":"Microorganisms"},{"key":"2560_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2334-13-101","volume":"13","author":"EZ Gebremedhin","year":"2013","unstructured":"Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, et al. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis. 2013;13:101.","journal-title":"BMC Infect Dis"},{"key":"2560_CR30","first-page":"80","volume":"22","author":"F Lv","year":"2014","unstructured":"Lv F, Xie D, Chen M. Analyzed the TORCH screening of free pre-pregnancy health examination of 210 000 people in Guangxi. Chin J Birth Health Heredity. 2014;22:80\u20132.","journal-title":"Chin J Birth Health Heredity"},{"key":"2560_CR31","first-page":"55","volume":"33","author":"Y Feng, Jin","year":"2014","unstructured":"Feng, Jin Y, Han W. Analysis of the TORCH detection results among 193490 pre-pregnancy women underwent eugenic health check in Liaoning province. China & Foreign Medical Treatment. 2014;33:55\u20136.","journal-title":"China & Foreign Medical Treatment"},{"key":"2560_CR32","doi-asserted-by":"crossref","first-page":"1900710","DOI":"10.2807\/1560-7917.ES.2021.26.5.1900710","volume":"26","author":"E Robinson","year":"2021","unstructured":"Robinson E, de Valk H, Villena I, Le Strat Y, Tourdjman M. National perinatal survey demonstrates a decreasing seroprevalence of Toxoplasma gondii infection among pregnant women in France, 1995 to 2016: impact for screening policy. Euro Surveill. 2021;26:1900710.","journal-title":"Euro Surveill"},{"key":"2560_CR33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1186\/s12879-021-06658-8","volume":"21","author":"EAJ Cook","year":"2021","unstructured":"Cook EAJ, Gitahi N, de Glanville WA, Thomas LF, Kariuki S, Kang\u2019ethe E, et al. Prevalence and risk factors for exposure to Toxoplasma gondii in slaughterhouse workers in western Kenya. BMC Infect Dis. 2021;21:944.","journal-title":"BMC Infect Dis"},{"key":"2560_CR34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/trstmh\/traa153","volume":"115","author":"LMR Antinarelli","year":"2021","unstructured":"Antinarelli LMR, Silva MR, Guimar\u00e3es RJ, de PS, Terror MS, Lima PE, Ishii J, de SC, et al. Rural residence remains a risk factor for Toxoplasma infection among pregnant women in a highly urbanized brazilian area: a robust cross-sectional study. Trans R Soc Trop Med Hyg. 2021;115:896\u2013903.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2560_CR35","doi-asserted-by":"crossref","unstructured":"Avelar MV, Martinez VO, de Moura DL, Barros IA, Primo AA da, Duarte S et al. AO,. Association between seroprevalence of IgG anti-Toxoplasma gondii and risk factors for infection among pregnant women in Clim\u00e9rio de Oliveira Maternity, Salvador, Bahia, Brazil. Rev Inst Med trop S Paulo. 2017;59.","DOI":"10.1590\/s1678-9946201759090"},{"key":"2560_CR36","doi-asserted-by":"crossref","unstructured":"Costa GB, De Oliveira MC, Gadelha SR, Albuquerque GR, Teixeira M, Raiol MR da. Infectious diseases during pregnancy in Brazil: seroprevalence and risk factors. J Infect Dev Ctries. 2018;12:657\u201365.","DOI":"10.3855\/jidc.9492"},{"key":"2560_CR37","doi-asserted-by":"crossref","unstructured":"Ju D, Li XZ, Shi YF, Li Y, Guo LQ, Zhang Y. Cytomegalovirus shedding in seropositive healthy women of reproductive age in Tianjin, China. Epidemiol Infect 148:e34.","DOI":"10.1017\/S0950268820000217"},{"key":"2560_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/jiz443","volume":"221 Supplement1","author":"MM Mussi-Pinhata","year":"2020","unstructured":"Mussi-Pinhata MM, Yamamoto AY. Natural history of congenital cytomegalovirus infection in highly seropositive populations. J Infect Dis. 2020;221 Supplement1:15\u201322.","journal-title":"J Infect Dis"},{"key":"2560_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejogrb.2020.09.010","volume":"254","author":"Y Qi","year":"2020","unstructured":"Qi Y, Zhu S, Li C, Wu H, Yue H, Zhang Y, et al. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China. Eur J Obstet Gynecol Reproductive Biology. 2020;254:114\u20138.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"2560_CR40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4014\/jmb.1612.12020","volume":"27","author":"Q Jin","year":"2017","unstructured":"Jin Q, Su J, Wu S. Cytomegalovirus infection among pregnant women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions. J Microbiol Biotechnol. 2017;27:1005\u20139.","journal-title":"J Microbiol Biotechnol"},{"key":"2560_CR41","first-page":"314","volume":"26","author":"J Meng","year":"2010","unstructured":"Meng J, Qin G, Wei Y. Epidemiological analysis on outbreak of Rubella in Middle School in Remote Minority Area. J Med Pest Control. 2010;26:314\u20136.","journal-title":"J Med Pest Control"},{"key":"2560_CR42","doi-asserted-by":"crossref","first-page":"799873","DOI":"10.3389\/fmed.2021.799873","volume":"8","author":"W Jing","year":"2022","unstructured":"Jing W, Yuan Y, Liu M, Ye H, Kong C, Liu J, et al. Ethnic disparities in Hepatitis B virus infection among 1 million Reproductive-Age couples preparing for pregnancy in the rural Yunnan, China: a Population-Based cross-sectional study. Front Med (Lausanne). 2022;8:799873.","journal-title":"Front Med (Lausanne)"},{"key":"2560_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijgo.2016.03.032","volume":"135","author":"TM Lanzieri","year":"2016","unstructured":"Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR. Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20\u201349 years in the USA. Int J Gynaecol Obstet. 2016;135:82\u20135.","journal-title":"Int J Gynaecol Obstet"},{"key":"2560_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12879-018-3032-x","volume":"18","author":"Q Meng","year":"2018","unstructured":"Meng Q, Luo J, Li L, Shi W, Yu J, Shen Y, et al. Rubella seroprevalence among pregnant women in Beijing, China. BMC Infect Dis. 2018;18:130.","journal-title":"BMC Infect Dis"},{"key":"2560_CR45","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1473-3099(20)30475-8","volume":"21","author":"Q Su","year":"2021","unstructured":"Su Q, Feng Z, Hao L, Ma C, Hagan JE, Grant GB, et al. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study. Lancet Infect Dis. 2021;21:1004\u201313.","journal-title":"Lancet Infect Dis"},{"key":"2560_CR46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fimmu.2020.00555","volume":"11","author":"M Albrecht","year":"2020","unstructured":"Albrecht M, Arck PC. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front Immunol. 2020;11:555.","journal-title":"Front Immunol"},{"key":"2560_CR47","first-page":"2384","volume":"46","author":"Y Li","year":"2019","unstructured":"Li Y, Xu D, Zheng Y, Yan H, Li S, Yi S. Analysis of TORCH infection of 301057 women during prepregnant health examination in Hubei. Mod Prev Med. 2019;46:2384\u201387.","journal-title":"Mod Prev Med"},{"key":"2560_CR48","first-page":"56","volume":"20","author":"H Xu","year":"2020","unstructured":"Xu H, Yu J, Wang Q, Liu H, Wu W. Health examination results of pre-pregnancy eugenics of couples of childbearing age in Hainan, 2017\u20132018. China Trop Med. 2020;20:56\u201360.","journal-title":"China Trop Med"},{"key":"2560_CR49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/JCM.01264-11","volume":"50","author":"Z Zhu","year":"2012","unstructured":"Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50:353\u201363.","journal-title":"J Clin Microbiol"},{"key":"2560_CR50","doi-asserted-by":"crossref","first-page":"e0178122","DOI":"10.1371\/journal.pone.0178122","volume":"12","author":"M Fabiani","year":"2017","unstructured":"Fabiani M, Ferrante G, Minardi V, Giambi C, Riccardo F, Declich S, et al. Comparison of rubella immunization rates in immigrant and italian women of childbearing age: results from the italian behavioral surveillance system PASSI (2011\u20132015). PLoS ONE. 2017;12:e0178122.","journal-title":"PLoS ONE"},{"key":"2560_CR51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/322651","volume":"33","author":"CA Dykewicz","year":"2001","unstructured":"Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, et al. Rubella seropositivity in the United States, 1988\u20131994. Clin Infect Dis. 2001;33:1279\u201386.","journal-title":"Clin Infect Dis"},{"key":"2560_CR52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.inhe.2010.03.004","volume":"2","author":"M-D Amina","year":"2010","unstructured":"Amina M-D, Oladapo S, Habib S, Adebola O, Bimbo K, Daniel A. Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria. Int Health. 2010;2:156\u20139.","journal-title":"Int Health"},{"key":"2560_CR53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/21645515.2019.1688041","volume":"16","author":"S Marchi","year":"2020","unstructured":"Marchi S, Viviani S, Montomoli E, Trombetta CM. Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Hum Vaccines Immunotherapeutics. 2020;16:895\u20138.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2560_CR54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1701-2163(16)32740-2","volume":"30","author":"L Dontigny","year":"2008","unstructured":"Dontigny L, Arsenault M-Y, Martel M-J. Clinical practice obstetrics committee. Rubella in pregnancy. J Obstet Gynaecol Can. 2008;30:152\u20138.","journal-title":"J Obstet Gynaecol Can"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02560-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:07:12Z","timestamp":1700305632000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02560-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02560-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approval by the Institutional Review Board of the Chinese Association of Maternal and Child Health Studies (IRB-201001). Before enrolment all participants provided a written informed consent. We confirmed that all methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"425"}}